Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 238

1.

Chemoresistance to doxorubicin and cisplatin in a murine cell line. Analysis of P-glycoprotein, topoisomerase II activity, glutathione and related enzymes.

Mestdagh N, Pommery N, Saucier JM, Hecquet B, Fournier C, Slomianny C, Teissier E, Hénichart JP.

Anticancer Res. 1994 May-Jun;14(3A):869-74.

PMID:
7915509
[PubMed - indexed for MEDLINE]
2.

HT1080/DR4: a P-glycoprotein-negative human fibrosarcoma cell line exhibiting resistance to topoisomerase II-reactive drugs despite the presence of a drug-sensitive topoisomerase II.

Zwelling LA, Slovak ML, Doroshow JH, Hinds M, Chan D, Parker E, Mayes J, Sie KL, Meltzer PS, Trent JM.

J Natl Cancer Inst. 1990 Oct 3;82(19):1553-61.

PMID:
1976136
[PubMed - indexed for MEDLINE]
4.

Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.

Kiura K, Ohnoshi T, Tabata M, Shibayama T, Kimura I.

Acta Med Okayama. 1993 Jun;47(3):191-7.

PMID:
8104372
[PubMed - indexed for MEDLINE]
5.

Mechanisms of resistance of human small cell lung cancer lines selected in VP-16 and cisplatin.

Jain N, Lam YM, Pym J, Campling BG.

Cancer. 1996 May 1;77(9):1797-808.

PMID:
8646677
[PubMed - indexed for MEDLINE]
6.
7.

A study of the mechanism of resistance to Adriamycin in vivo. Glutathione metabolism, P-glycoprotein expression, and drug transport.

Lee FY, Sciandra J, Siemann DW.

Biochem Pharmacol. 1989 Nov 1;38(21):3697-705.

PMID:
2574574
[PubMed - indexed for MEDLINE]
8.

Multifactorial mechanisms associated with broad cross-resistance of ovarian carcinoma cells selected by cyanomorpholino doxorubicin.

Lau DH, Lewis AD, Ehsan MN, Sikic BI.

Cancer Res. 1991 Oct 1;51(19):5181-7.

PMID:
1717140
[PubMed - indexed for MEDLINE]
Free Article
9.

Progressive resistance to doxorubicin in mouse leukemia L1210 cells with multidrug resistance phenotype: reductions in drug-induced topoisomerase II-mediated DNA cleavage.

Ganapathi R, Grabowski D, Ford J, Heiss C, Kerrigan D, Pommier Y.

Cancer Commun. 1989;1(4):217-24.

PMID:
2576973
[PubMed - indexed for MEDLINE]
10.

P-glycoprotein but not topoisomerase II and glutathione-S-transferase-pi accounts for enhanced intracellular drug-resistance in LoVo MDR human cell lines.

Boiocchi M, Tumiotto L, Giannini F, Viel A, Biscontin G, Sartor F, Toffoli G.

Tumori. 1992 Jun 30;78(3):159-66.

PMID:
1359686
[PubMed - indexed for MEDLINE]
11.

Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors.

Efferth T, Mattern J, Volm M.

Oncology. 1992;49(5):368-75.

PMID:
1356260
[PubMed - indexed for MEDLINE]
12.

Characterization of four doxorubicin adapted human breast cancer cell lines with respect to chemotherapeutic drug sensitivity, drug resistance associated membrane proteins and glutathione transferases.

de la Torre M, Hao XY, Larsson R, Nygren P, Tsuruo T, Mannervik B, Bergh J.

Anticancer Res. 1993 Sep-Oct;13(5A):1425-30.

PMID:
7902062
[PubMed - indexed for MEDLINE]
13.

Modulation of multidrug resistance in a cancer cell line by anti-multidrug resistance-associated protein (MRP) ribozyme.

Hatanaka H, Abe Y, Naruke M, Asai S, Miyachi H, Kawakami T, Nagata J, Kamochi J, Kijima H, Yamazaki H, Scanlon KJ, Ueyama Y, Nakamura M.

Anticancer Res. 2001 Mar-Apr;21(2A):879-85.

PMID:
11396179
[PubMed - indexed for MEDLINE]
14.

Characterization of adriamycin-resistant human breast cancer cells which display overexpression of a novel resistance-related membrane protein.

Chen YN, Mickley LA, Schwartz AM, Acton EM, Hwang JL, Fojo AT.

J Biol Chem. 1990 Jun 15;265(17):10073-80.

PMID:
1972154
[PubMed - indexed for MEDLINE]
Free Article
15.

Multifactorial resistance to antineoplastic agents in drug-resistant P388 murine leukemia, Chinese hamster ovary, and human HeLa cells, with emphasis on the role of DNA topoisomerase II.

Deffie AM, McPherson JP, Gupta RS, Hedley DW, Goldenberg GJ.

Biochem Cell Biol. 1992 May;70(5):354-64.

PMID:
1353968
[PubMed - indexed for MEDLINE]
16.

Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.

Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller CP, Dopfer R, Klingebiel T, Diddens H, et al.

Br J Cancer. 1992 Sep;66(3):507-17.

PMID:
1355660
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Multifactorial resistance to adriamycin: relationship of DNA repair, glutathione transferase activity, drug efflux, and P-glycoprotein in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.

Deffie AM, Alam T, Seneviratne C, Beenken SW, Batra JK, Shea TC, Henner WD, Goldenberg GJ.

Cancer Res. 1988 Jul 1;48(13):3595-602.

PMID:
2897875
[PubMed - indexed for MEDLINE]
Free Article
18.

Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.

Hamaguchi K, Godwin AK, Yakushiji M, O'Dwyer PJ, Ozols RF, Hamilton TC.

Cancer Res. 1993 Nov 1;53(21):5225-32.

PMID:
8106143
[PubMed - indexed for MEDLINE]
Free Article
19.

A study of cross-resistance pattern and expression of molecular markers of multidrug resistance in a human small-cell lung-cancer cell line selected with doxorubicin.

Supino R, Binaschi M, Capranico G, Gambetta RA, Prosperi E, Sala E, Zunino F.

Int J Cancer. 1993 May 8;54(2):309-14.

PMID:
8098017
[PubMed - indexed for MEDLINE]
20.

Stable differentiation of a human colon adenocarcinoma cell line by sodium butyrate is associated with multidrug resistance.

Ho SB, Yan PS, Dahiya R, Neuschwander-Tetri BA, Basbaum C, Kim YS.

J Cell Physiol. 1994 Aug;160(2):213-26.

PMID:
7913708
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk